CUSIP: M47238122
What is CUSIP M47238122?
CUSIP M47238122 identifies GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP M47238122:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q3 | 0 | $0 | -$99,436 | 0 | |
| 2024 Q2 | 396,731 | $112,946 | +$62,648 | $0.28 | 11 |
| 2024 Q1 | 172,456 | $57,609 | -$128,564 | $0.35 | 11 |
| 2023 Q4 | 546,788 | $248,791 | -$74,579 | $0.46 | 12 |
| 2023 Q3 | 691,438 | $429,211 | +$74,839 | $0.62 | 16 |
| 2023 Q2 | 143,537 | $419,148 | +$419,148 | $2.99 | 12 |